Accelerating clinical trials in the EU: publication of 2022-2026 workplan

EMA

30 August 2022 - The European Commission, the Heads of Medicines Agencies and the EMA have published the  2022-2026 workplan of the initiative Accelerating Clinical Trials in the EU (ACT EU).

ACT EU, launched in January 2022, seeks to transform how clinical trials are initiated, designed and run.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder